应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TAOX Tao Synergies Inc.
盘前交易 07-29 09:29:39 EDT
6.52
-1.89
-22.47%
盘前
6.97
+0.45
+6.90%
09:27 EDT
最高
8.82
最低
6.51
成交量
41.45万
今开
8.82
昨收
8.41
日振幅
27.47%
总市值
1,518万
流通市值
1,464万
总股本
232.87万
成交额
305.36万
换手率
18.46%
流通股本
224.56万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
上市公司 TAO Synergies 斥资 1000万 美元购入 TAO 代币作为储备
链捕手 · 07-18
上市公司 TAO Synergies 斥资 1000万 美元购入 TAO 代币作为储备
Synaptogenix, Inc.盘中异动 早盘急速上涨8.02%
市场透视 · 06-30
Synaptogenix, Inc.盘中异动 早盘急速上涨8.02%
Synaptogenix, Inc.6月23日成交额为96.02万美元
市场透视 · 06-24
Synaptogenix, Inc.6月23日成交额为96.02万美元
加载更多
公司概况
公司名称:
Tao Synergies Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
TAO Synergies Inc.于2012年10月31日在特拉华州注册成立。该公司是一家生物制药公司,拥有处于临床前和临床开发阶段的候选产品。该公司主要专注于开发基于一种名为Bryostatin-1的候选药物的产品平台,该药物由从海洋无脊椎动物生物体中分离出来的天然产物(bryostatin)合成,用于治疗阿尔茨海默病(“AD”),该药物正处于临床测试阶段。
发行价格:
--
{"stockData":{"symbol":"TAOX","market":"US","secType":"STK","nameCN":"Tao Synergies Inc.","latestPrice":6.52,"timestamp":1753732800000,"preClose":8.41,"halted":0,"volume":414490,"hourTrading":{"tag":"盘前","latestPrice":6.97,"preClose":6.52,"latestTime":"09:27 EDT","volume":1559,"amount":10264.6575787,"timestamp":1753795624153},"delay":0,"floatShares":2245600,"shares":2328690,"eps":-9.900128,"marketStatus":"盘前交易","change":-1.89,"latestTime":"07-29 09:29:39 EDT","open":8.82,"high":8.82,"low":6.51,"amount":3053636.11637,"amplitude":0.274673,"askPrice":6.97,"askSize":25,"bidPrice":6.75,"bidSize":560,"shortable":0,"etf":0,"ttmEps":-9.900128,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753795800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":6.52,"preHourTrading":{"tag":"盘前","latestPrice":6.97,"preClose":6.52,"latestTime":"09:27 EDT","volume":1559,"amount":10264.6575787,"timestamp":1753795624153},"postHourTrading":{"tag":"盘后","latestPrice":6.99,"preClose":6.52,"latestTime":"19:59 EDT","volume":5640,"amount":37987.5052,"timestamp":1753747150321},"volumeRatio":1.736697445075011},"requestUrl":"/m/hq/s/TAOX","defaultTab":"news","newsList":[{"id":"2552016461","title":"上市公司 TAO Synergies 斥资 1000万 美元购入 TAO 代币作为储备","url":"https://stock-news.laohu8.com/highlight/detail?id=2552016461","media":"链捕手","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552016461?lang=zh_cn&edition=full","pubTime":"2025-07-18 18:15","pubTimestamp":1752833708,"startTime":"0","endTime":"0","summary":"ChainCatcher 消息,据美通社报道,TAO Synergies Inc. 宣布,截至 2025 年 7 月 17 日,已按照公司针对 Bittensor 原生代币 TAO 制定的数字资产储备战略,以约每枚334美元的平均价格,斥资 1000 万美元购入 29,899 枚 TAO 代币。TAO Synergies 现已成为全球最大的公开上市纯 TAO 代币持有者。关联标签TAO Synergies TAO 代币 数字资产储备链捕手ChainCatcher提醒,请广大读者理性看待区块链,切实提高风险意识,警惕各类虚拟代币发行与炒作, 站内所有内容仅系市场信息或相关方观点,不构成任何形式投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071818162097aafd19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071818162097aafd19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TAOX","BK4139","TAO"],"gpt_icon":0},{"id":"2547977660","title":"Synaptogenix, Inc.盘中异动 早盘急速上涨8.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547977660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547977660?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:32","pubTimestamp":1751290340,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时32分,Synaptogenix, Inc.股票出现异动,股价大幅拉升8.02%。Synaptogenix, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Eyenovia, Inc.涨幅较大,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃,换手率分别为2079.66%、113.99%、61.61%,振幅较大的相关个股有Artelo Biosciences, Inc.、Eyenovia, Inc.、Exicure, Inc.,振幅分别为43.74%、19.21%、16.13%。Synaptogenix, Inc.公司简介:Synaptogenix Inc 是一家生物制药公司,在临床前和临床开发中具有产品候选者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213220a4c6c4b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213220a4c6c4b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TAOX","SNPX","BK4139"],"gpt_icon":0},{"id":"2545634472","title":"Synaptogenix, Inc.6月23日成交额为96.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545634472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545634472?lang=zh_cn&edition=full","pubTime":"2025-06-24 14:01","pubTimestamp":1750744898,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,Synaptogenix, Inc.成交额为96.02万美元,成交额较昨日增加3.36%,当日成交量为26.46万股。Synaptogenix, Inc.于2025年6月23日跌16.74%,报3.58美元,该股过去5个交易日跌3.5%,年初至今涨3.17%,过去60日涨35.61%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-23|96.02万|3.36%|26.46万|#|2025-06-20|92.90万|81.39%|21.94万|#|2025-06-18|51.22万|-37.75%|12.89万|#|2025-06-17|82.28万|-20.88%|20.97万|#|2025-06-16|104.00万|-44.75%|24.79万|Synaptogenix Inc 是一家生物制药公司,在临床前和临床开发中具有产品候选者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624140145a4badf04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624140145a4badf04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNPX","TAOX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.synaptogen.com","stockEarnings":[{"period":"1week","weight":-0.2921},{"period":"1month","weight":0.0786},{"period":"3month","weight":1.7453},{"period":"6month","weight":0.8251},{"period":"1year","weight":0.5341},{"period":"ytd","weight":0.879}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TAO Synergies Inc.于2012年10月31日在特拉华州注册成立。该公司是一家生物制药公司,拥有处于临床前和临床开发阶段的候选产品。该公司主要专注于开发基于一种名为Bryostatin-1的候选药物的产品平台,该药物由从海洋无脊椎动物生物体中分离出来的天然产物(bryostatin)合成,用于治疗阿尔茨海默病(“AD”),该药物正处于临床测试阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.127459},{"month":2,"riseRate":0.4,"avgChangeRate":0.126015},{"month":3,"riseRate":0.2,"avgChangeRate":-0.086787},{"month":4,"riseRate":0.8,"avgChangeRate":-0.019924},{"month":5,"riseRate":0.4,"avgChangeRate":-0.038398},{"month":6,"riseRate":0.6,"avgChangeRate":0.501694},{"month":7,"riseRate":0.2,"avgChangeRate":-0.07245},{"month":8,"riseRate":0.25,"avgChangeRate":-0.02833},{"month":9,"riseRate":0.25,"avgChangeRate":-0.037469},{"month":10,"riseRate":0.5,"avgChangeRate":-0.07233},{"month":11,"riseRate":0,"avgChangeRate":-0.095254},{"month":12,"riseRate":0.5,"avgChangeRate":-0.159791}],"exchange":"NASDAQ","name":"Tao Synergies Inc.","nameEN":"Tao Synergies Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tao Synergies Inc.(TAOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tao Synergies Inc.(TAOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tao Synergies Inc.,TAOX,Tao Synergies Inc.股票,Tao Synergies Inc.股票老虎,Tao Synergies Inc.股票老虎国际,Tao Synergies Inc.行情,Tao Synergies Inc.股票行情,Tao Synergies Inc.股价,Tao Synergies Inc.股市,Tao Synergies Inc.股票价格,Tao Synergies Inc.股票交易,Tao Synergies Inc.股票购买,Tao Synergies Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tao Synergies Inc.(TAOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tao Synergies Inc.(TAOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}